Steven Stein
Net worth: 8 M $ as of 31/05/2026
Net worth: 8 M $ as of 31/05/2026
Steven H. Stein holds the position of Chief Medical Officer & Executive Vice President at Incyte Corp. Dr. Stein is also on the board of Kura Oncology, Inc. In his past career Dr. Stein was Vice President-Global Oncology at GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs at Novartis Oncology, Inc. and Senior VP-US Clinical Development & Medical Affair at Novartis Pharmaceuticals Corp. Dr. Stein received a doctorate from the University of the Witwatersrand.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INCYTE CORPORATION 0.04% | 06/05/2026 | 78,327 ( 0.04% ) | 8 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 02/03/2015 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| REPARE THERAPEUTICS INC. | Director/Board Member | 28/01/2026 |
| THESEUS PHARMACEUTICALS, INC. | Director/Board Member | 14/02/2024 |
| KURA ONCOLOGY, INC. | Director/Board Member | 01/05/2023 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/02/2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/02/2015 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Repare Therapeutics, Inc.
Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Select your edition
All financial news and data tailored to specific country editions